| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.586 | 1.491 | 2.731 | 513 | 502 | 265 | 1.259 | 1.521 | 0 | 45.377 |
| Total Income - EUR | 8.669 | 1.506 | 2.756 | 524 | 502 | 265 | 1.259 | 1.521 | 0 | 45.996 |
| Total Expenses - EUR | 7.925 | 1.205 | 2.506 | 570 | 552 | 31 | 2.183 | 34 | 27 | 22.017 |
| Gross Profit/Loss - EUR | 744 | 301 | 250 | -46 | -50 | 234 | -924 | 1.487 | -27 | 23.979 |
| Net Profit/Loss - EUR | 486 | 256 | 167 | -62 | -65 | 227 | -962 | 1.442 | -27 | 20.140 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biomeding Osteonica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 977 |
| Current Assets | 2.731 | 3.169 | 1.839 | 1.788 | 1.642 | 2.074 | 837 | 2.282 | 1.283 | 25.855 |
| Inventories | 0 | 250 | 0 | 55 | 0 | 232 | 0 | 0 | 0 | 4.945 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Cash | 2.730 | 2.919 | 1.839 | 1.733 | 1.642 | 1.842 | 837 | 2.281 | 1.282 | 20.910 |
| Shareholders Funds | 1.628 | 665 | 821 | 744 | 664 | 879 | -102 | 1.339 | 343 | 20.481 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.103 | 2.504 | 1.019 | 1.044 | 978 | 1.195 | 940 | 943 | 940 | 6.351 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Biomeding Osteonica S.r.l.